Inspire Investing’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
42,947
-247
| -0.6% | -$2.25K | 0.04% | 441 |
|
|
2025
Q1 | $343K | Sell |
43,194
-32,119
| -43% | -$255K | 0.04% | 586 |
|
|
2024
Q4 | $409K | Buy |
75,313
+17,541
| +30% | +$95.2K | 0.05% | 359 |
|
|
2024
Q3 | $417K | Buy |
57,772
+25,139
| +77% | +$182K | 0.04% | 372 |
|
|
2024
Q2 | $354K | Buy |
32,633
+13,399
| +70% | +$146K | 0.04% | 427 |
|
|
2024
Q1 | $360K | Buy |
19,234
+1,652
| +9% | +$31K | 0.04% | 468 |
|
|
2023
Q4 | $381K | Buy |
17,582
+2,533
| +17% | +$54.9K | 0.04% | 755 |
|
|
2023
Q3 | $310K | Buy |
15,049
+1,169
| +8% | +$24.1K | 0.04% | 429 |
|
|
2023
Q2 | $653K | Buy |
13,880
+622
| +5% | +$29.2K | 0.08% | 244 |
|
|
2023
Q1 | $556K | Buy |
13,258
+6,809
| +106% | +$286K | 0.07% | 206 |
|
|
2022
Q4 | $246K | Buy |
6,449
+848
| +15% | +$32.3K | 0.03% | 346 |
|
|
2022
Q3 | $219K | Sell |
5,601
-932
| -14% | -$36.4K | 0.03% | 335 |
|
|
2022
Q2 | $211K | Sell |
6,533
-20,891
| -76% | -$675K | 0.03% | 690 |
|
|
2022
Q1 | $908K | Buy |
27,424
+21,531
| +365% | +$713K | 0.11% | 177 |
|
|
2021
Q4 | $251K | Buy |
5,893
+745
| +14% | +$31.7K | 0.03% | 410 |
|
|
2021
Q3 | $228K | Buy |
5,148
+1,122
| +28% | +$49.7K | 0.03% | 641 |
|
|
2021
Q2 | $229K | Sell |
4,026
-10,643
| -73% | -$605K | 0.03% | 574 |
|
|
2021
Q1 | $1.1M | Buy |
14,669
+12,251
| +507% | +$917K | 0.17% | 124 |
|
|
2020
Q4 | $209K | Buy |
+2,418
| New | +$209K | 0.05% | 605 |
|
|
2018
Q1 | – | Sell |
-351
| Closed | -$58K | – | 603 |
|
|
2017
Q4 | $58K | Buy |
+351
| New | +$58K | 0.05% | 412 |
|